Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

1.3K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.3K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

966
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
966
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

485
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
485
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

779
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
779
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

559
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
559
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.5K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adverse Perinatal Outcomes by Gestational Surrogacy Status among In Vitro Fertilization Pregnancies.

American journal of perinatology·2026
Same author

Does asthma treatment influence COVID-19 severity? A comparative cohort study of SMART vs. Traditional therapy.

European clinical respiratory journal·2026
Same author

Drivers of disparities in asthma exacerbation and healthcare utilization: a quantitative analysis of neighborhood deprivation in Southern California, United States.

Preventive medicine reports·2026
Same author

Research on the impact mechanism of environmental perception of stadium landscapes on sustainable spectatorship willingness from the perspective of embodied cognition: based on the experience model of "body-environment" interaction.

Frontiers in psychology·2026
Same author

Health Care Use and Recurrence Rate in Hemolytic Disease of the Fetus and Newborn: Retrospective Cohort Study.

JMIR pediatrics and parenting·2026
Same author

Analysis of configurational elements of the sense of belonging in sports participation among urban new migrants in the context of China's development.

Computational biology and chemistry·2026

Related Experiment Video

Updated: Apr 12, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.7K

Risk factor profiles and haemodynamic progression in aortic stenosis: a retrospective population-based study.

Ming-Sum Lee1, Matt Zhou2, Michael Ho3

  • 1Department of Cardiology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, USA mingsum.lee@kp.org.

Heart (British Cardiac Society)
|April 10, 2026
PubMed
Summary
This summary is machine-generated.

Aortic stenosis (AS) progression varies by severity. Identifying risk factors like anaemia and obesity can help predict rapid deterioration and guide patient monitoring.

Keywords:
Aortic Valve Stenosis

More Related Videos

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.2K
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.7K

Related Experiment Videos

Last Updated: Apr 12, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.7K
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.2K
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.7K

Area of Science:

  • Cardiology
  • Medical Research
  • Clinical Epidemiology

Background:

  • Aortic stenosis (AS) is a progressive condition with unpredictable progression rates.
  • Current surveillance may not identify patients at high risk for rapid hemodynamic decline.
  • Real-world data is needed to understand AS progression and identify risk factors.

Purpose of the Study:

  • To assess AS progression rates using longitudinal data.
  • To identify clinical and echocardiographic factors associated with rapid AS progression.
  • To improve risk stratification for AS patient monitoring.

Main Methods:

  • Retrospective cohort study of 70,850 adults with at least two transthoracic echocardiograms (TTEs).
  • Data collected from an integrated healthcare system between 2011 and 2021.
  • Multivariable logistic regression identified predictors of rapid progression (annualized Vmax increase ≥0.3 m/s/year).

Main Results:

  • Rapid AS progression observed in 7.8% (aortic sclerosis), 16.4% (mild AS), and 29.8% (moderate AS).
  • Factors associated with rapid progression varied by baseline AS severity.
  • Older age, anemia, liver disease, renal failure, obesity, and comorbidities were linked to faster progression in earlier stages.

Conclusions:

  • AS progression is heterogeneous, influenced by baseline severity and patient risk profiles.
  • Integrating clinical and echocardiographic factors can enhance identification of patients needing closer surveillance.
  • This approach may facilitate earlier intervention for high-risk individuals.